YARW SCHEDULE 13G: SEC filing

Filed with the SEC on · accession 0001193125-26-462440

YARW filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 16, 2026. Ameriprise Financial Inc., through its subsidiary Columbia Management Investment Advisers LLC and Columbia Small Cap Growth Fund, filed a Schedule 13G reporting beneficial ownership of 8.6% of Yarrow Bioscience's common stock as of September 30, 2026. The stock moved -22.7% by the first close after the filing.

Summary of the filing

Ameriprise Financial Inc., through its subsidiary Columbia Management Investment Advisers LLC and Columbia Small Cap Growth Fund, filed a Schedule 13G reporting beneficial ownership of 8.6% of Yarrow Bioscience's common stock as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(b).

Key details

Shares beneficially owned by Ameriprise Financial, Inc. and Columbia Management Investment Advisers, LLC$740K
Shares beneficially owned by Columbia Small Cap Growth Fund$539K
Reporting person / parent holding companyAmeriprise Financial, Inc.
Reporting person / investment adviserColumbia Management Investment Advisers, LLC
Reporting person / beneficial owner of more than 5%Columbia Small Cap Growth Fund
IssuerYarrow Bioscience, Inc.
Senior vice president, north america head of operations & investor servicesMichael G. Clarke

How YARW stock reacted

Close before

$18.03

Nov 13, 2026

First close after

-22.74%

$13.93

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for YARW, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for YARW?

Click here

Frequently asked questions

What did YARW file with the SEC on Nov 16, 2026?

YARW filed a SCHEDULE 13G (SEC filing). Ameriprise Financial Inc., through its subsidiary Columbia Management Investment Advisers LLC and Columbia Small Cap Growth Fund, filed a Schedule 13G reporting beneficial ownership of 8.6% of Yarrow Bioscience's common stock as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(b).

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did YARW stock react to this filing?

YARW closed at $18.03 before the filing and $13.93 on Nov 16, 2026 (-22.74%).

Other YARW SEC filings

Get alerts when YARW files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days